EU Commissioner commends work on HIPODERM project

The EU Commissioner for Research, Innovation and Science, Máire Geoghegan Quinn visited Waterford Institute of Technology today and took time to meet the researchers working on the High Potency Dermatologicals (HIPODERM) project.  HIPODERM is led by the PMBRC and aims to develop technologies for delivering drugs across the skin. The consortium also consists of EirGen Pharma in Waterford as well as Cardiff University and An-eX Analytical Services, both in Wales. Click here for more information on the HIPODERM project.

Dr. Marc Kelly, a Marie Curie Fellow working with EirGen Pharma, explained the background of the project to the Commissioner including a demonstration of how microneedle arrays can be used to bypass the skin barrier to deliver drugs. Commending the research, Commissioner Geoghegan Quinn stated that it was an excellent example of how European funding schemes could be used to enable SMEs access expertise across Europe by working with academic partners.

Máre Geoghegan Quinn

Pictured left to right: Dr. Niall O'Reilly, PMBRC Manager; Máire Geoghegan Quinn, EU Commissioner for Research, Innovation and Science; Dr. Helen Hughes, HIPODERM research supervisor; Dr. Marc Kelly, Marie Curie fellow with EirGen Pharma.

Marc Kelly

Dr. Marc Kelly, Marie Curie research fellow with EirGen Pharma explains the background of the HIPODERM project to Commissioner Máire Geoghegan Quinn.